Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Brent Rexer

3 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Basic Science

    VICCBRE1696

    06/15/2017

    Plasma Tumor DNA and Pathologic Complete Response in Early-Stage, High-Risk Breast Cancer

    Treatment

    ECOGBRES1418

    03/17/2017

    A Randomized, Phase III Trial to Evaluate The Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with ≥ 1 cm Residual Invasive Cancer or Positive Lymph Nodes (yPN+) After Neoadjuvant Chemotherapy

    Treatment

    ECOGBREA011401

    12/16/2016

    Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer


    Print this page for your doctor